FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies
Open Access
- 19 April 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 880077
Abstract
FBXW7, a member of the F-box protein family within the ubiquitin–proteasome system, performs an indispensable role in orchestrating cellular processes through ubiquitination and degradation of its substrates, such as c-MYC, mTOR, MCL-1, Notch, and cyclin E. Mainly functioning as a tumor suppressor, inactivation of FBXW7 induces the aberrations of its downstream pathway, resulting in the occurrence of diseases especially tumorigenesis. Here, we decipher the relationship between FBXW7 and the hallmarks of cancer and discuss the underlying mechanisms. Considering the interplay of cancer hallmarks, we propose several prospective strategies for circumventing the deficits of therapeutic resistance and complete cure of cancer patients.Keywords
This publication has 229 references indexed in Scilit:
- SREBPs: metabolic integrators in physiology and metabolismTrends in Endocrinology & Metabolism, 2012
- Negative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxiaJournal of Cellular Biochemistry, 2011
- SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destructionNature, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasisThe EMBO Journal, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: Clinical significanceInternational Journal of Cancer, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Autophagy in the Pathogenesis of DiseaseCell, 2008
- The Hallmarks of CancerCell, 2000